A comprehensive view of vaccination/immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer and Valneva to start late-stage clinical study of experimental VLA15 Lyme disease vaccination with 6,000 participants in US, northern Europe; in June, Pfizer invested US$92.3M in Valneva to support Lyme disease partnership

Moderna and EU amend COVID-19 vaccine agreement to allow Spikevax deliveries scheduled for July, August to be delivered later in the year to allow EU members to receive Omicron-specific vaccines; EU to buy an additional 15 million vaccine doses

Biontech reports Q2 net profits down at €1.7B from €2.8B a year ago, with revenue dropping to €3.2B from €5.3B a year ago; results driven by drop in revenue from COVID-19 vaccine as pandemic remains ‘dynamic’

Novavax starting Phase 2b/3 Hummingbird global clinical trial of its COVID-19 vaccine in children aged six months to 11 years old; trial to enroll 3,600 kids in US, Mexico, Europe, South America, Asia, Africa, with results by Q1 2023

Sanofi names Olivier Bogillot as head of US General Medicines responsible for serving diabetes, cardiovascular, transplant communities; Deborah Glasser named head of Vaccines, North America, to oversee US, Canada vaccine business

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count